Skip to main content

CrystaX awarded the ENISA Prize for Innovation

By 16 de November de 2007November 18th, 2020No Comments
< Back to news

CrystaX awarded the ENISA Prize for Innovation

The biotech firm , located within the Barcelona Science Park, has been awarded the ENISA Prize for Innovation in the life sciences category, the awards being given to mark the 25th anniversary of Spain's National Innovation Agency (). The awards aim to recognise entrepreneurial projects that represent clear progress in terms of innovation, whether this be setting up new companies or developing new projects.

The prize is worth 150,000 euro to CrystaX, and also offers the company the possibility of further competitive advantage awards of up to 800,000 euro. The prize was officially awarded in a ceremony held in Madrid’s Instituto Cervantes on 15 November and presided over by Joan Clos, the Minister for Industry, Tourism and Trade.

ENISA is a publicly-funded agency linked to the Ministry of Industry, Tourism and Trade via the General Policy Board for Small- and Medium-sized Companies. It was founded in 1982 and works in the area of financial investment, mainly in projects related to company start-up and growth.

There were 219 candidates in the current round of awards and the innovative projects put forward covered five different categories of technology: Life Sciences, Energy and the Environment, Industrial and Materials Technology, Means of Transport, and Information and Communications Technology.

CrystaX’s work focuses on the development of molecules of therapeutic interest via the structural determination of pharmacological targets. Set up by researchers from the Technical University of Catalonia (UPC) and Spain’s Higher Council for Scientific Research (CSIC) the company applies the latest developments in X-ray diffraction, nuclear magnetic resonance (NMR) studies and an emergent technology known as ‘fragment screening’ to optimize the creation of new candidate drugs.